Kjetil Hestdal • 1960 • Oslo • 7 roles • 7 shareholdings

This website uses cookies to enhance the user experience.

||

Roles

Management

Name	Role	Total operating income	Total equity	Shares
C CAEDO ONCOLOGY AS	Managing Director/CEO	1,836,881	34,536,141	5.5 % indirectly
S SERCA PHARMACEUTICALS AS	Managing Director/CEO	2,962,524	27,895,940	1.31 % indirectly

Boards

Name	Role	Total operating income	Total equity	Shares
K K OG K AS	Chairman	4,457,177	21,659,598	50 % directly
L LYTIX BIOPHARMA ASA	Board Member	11,134,000	107,894,000	-
A AUGERE MEDICAL AS Under liquidation	Board Member	1,159,800	27,660,381	-
N NILSEHOVDA VELFORENING	Chairman	-	-	-
A AKIGAI AS	Board Member	2,570,303	16,921,014	-

Last update: Oct 16, 2025

Related industries2

Direct relationships5

EP
Erlend Petter Skagseth1955
SERCA PHARMACEUTICALS AS, CAEDO ONCOLOGY AS
BK
Brynjar Kristian Forbergskog1958
LYTIX BIOPHARMA ASA
OJ
Ole Jesper Dahlberg1971
CAEDO ONCOLOGY AS
SN
Stig Nordal1966
AKIGAI AS
KS
Kristin Sandereid1968
SERCA PHARMACEUTICALS AS

Shares owned by Kjetil Hestdal

Name	Share class	Total operating income	Total equity	Share
K K OG K AS	Ordinære aksjer	4,457,177	21,659,598	50 % directly
C CAEDO ONCOLOGY AS		1,836,881	34,536,141	5.5 % indirectly
S SERCA PHARMACEUTICALS AS		2,962,524	27,895,940	1.31 % indirectly
H HAGA GOLF AS	NO0010118144	51,597,301	58,980,511	0.06 % directly < 0.01 %
L LYTIX BIOPHARMA ASA	NO0010405780	11,134,000	107,894,000	0.02 % directly < 0.01 %
V VISTIN PHARMA ASA	NO0010734122	0	184,035,000	< 0.01 % directly
M MEDISTIM ASA	NO0010159684	354,048,000	209,186,000	< 0.01 % directly

Limited to direct ownership positions of 0.5% or more.

Last update: Jun 2, 2025